Will clinical trials find Xenon inhalation to be safe and effective in humans as a treatment for Alzheimer's?
Health & MedicineOne-Off3y
Manifold MarketsNo KYCVerified resolution dataFairly calibratedCurrent community forecast
Safe but not effective. 49%Leader of 6 outcomes
Safe but not effective. 49%Forecasters
3
Question type
multiple choice
Methodology
Play-money forecasting platform
Source type
Forecast
7d Change
0.0 pts
Market data
Updated 12 hours ago
StaleJan 16, 25, 4:29 PM UTCJan 2, 30, 5:59 AM UTC
Trends
Rules
AD mouse model results:
- https://www.science.org/doi/10.1126/scitranslmed.adk3690
- Criteria are publication in a peer-reviewed journal, or official FDA or NIH announcement, or an equally reputable reader-suggested source to which there are no reader objections.
- If there is a human trial still ongoing by the expiration date, I will extend the date until it is complete.
- Efficacy is defined as formal FDA recognition of safety/efficacy.
- If FDA response is for some reason not going to be possible before the expiration date , then, at minimum: a statistically significant benefit to Alzheimer's patients compared to controls or a statistically significant correlation of this benefit with dosage or frequency of administration.
